News | April 20, 2026
Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
PMDA is regarded among the most stringent regulatory bodies globally
PMDA is regarded among the most stringent regulatory bodies globally
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Move strengthens footprint in Western India and expands multi-specialty care network
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Subscribe To Our Newsletter & Stay Updated
